Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2004 1
2005 1
2006 3
2007 3
2008 1
2009 2
2010 3
2011 7
2012 2
2013 6
2014 8
2015 10
2016 7
2017 9
2018 5
2019 5
2020 3
2021 3
2022 8
2023 5
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Liberal vs Restrictive Transfusion Thresholds on Survival and Neurocognitive Outcomes in Extremely Low-Birth-Weight Infants: The ETTNO Randomized Clinical Trial.
Franz AR, Engel C, Bassler D, Rüdiger M, Thome UH, Maier RF, Krägeloh-Mann I, Kron M, Essers J, Bührer C, Rellensmann G, Rossi R, Bittrich HJ, Roll C, Höhn T, Ehrhardt H, Avenarius S, Körner HT, Stein A, Buxmann H, Vochem M, Poets CF; ETTNO Investigators. Franz AR, et al. JAMA. 2020 Aug 11;324(6):560-570. doi: 10.1001/jama.2020.10690. JAMA. 2020. PMID: 32780138 Free PMC article. Clinical Trial.
Clinical trials in neonatal sepsis.
Oeser C, Lutsar I, Metsvaht T, Turner MA, Heath PT, Sharland M. Oeser C, et al. Among authors: metsvaht t. J Antimicrob Chemother. 2013 Dec;68(12):2733-45. doi: 10.1093/jac/dkt297. Epub 2013 Jul 30. J Antimicrob Chemother. 2013. PMID: 23904558 Review.
Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III).
Engel C, Rüdiger M, Benders MJNL, van Bel F, Allegaert K, Naulaers G, Bassler D, Klebermaß-Schrehof K, Vento M, Vilan A, Falck M, Mauro I, Metsäranta M, Vanhatalo S, Mazela J, Metsvaht T, van der Vlught R, Franz AR; ALBINO Study Group. Engel C, et al. Among authors: metsvaht t. Trials. 2024 Jan 24;25(1):81. doi: 10.1186/s13063-023-07828-6. Trials. 2024. PMID: 38267942 Free PMC article. Clinical Trial.
Medicines prescription patterns in European neonatal units.
Mesek I, Nellis G, Lass J, Metsvaht T, Varendi H, Visk H, Turner MA, Nunn AJ, Duncan J, Lutsar I. Mesek I, et al. Among authors: metsvaht t. Int J Clin Pharm. 2019 Dec;41(6):1578-1591. doi: 10.1007/s11096-019-00923-2. Epub 2019 Oct 17. Int J Clin Pharm. 2019. PMID: 31625122
Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.
Hill LF, Clements MN, Turner MA, Donà D, Lutsar I, Jacqz-Aigrain E, Heath PT, Roilides E, Rawcliffe L, Alonso-Diaz C, Baraldi E, Dotta A, Ilmoja ML, Mahaveer A, Metsvaht T, Mitsiakos G, Papaevangelou V, Sarafidis K, Walker AS, Sharland M; NeoVanc Consortium. Hill LF, et al. Among authors: metsvaht t. Lancet Child Adolesc Health. 2022 Jan;6(1):49-59. doi: 10.1016/S2352-4642(21)00305-9. Epub 2021 Nov 26. Lancet Child Adolesc Health. 2022. PMID: 34843669 Free PMC article. Clinical Trial.
88 results